Q3 2025 SP Group A/S Earnings Call Transcript
Key Points
- SP Group AS (OCSE:SPG) maintained its full-year guidance despite challenges, expecting a year similar to the record year in 2024.
- The company reported a strong growing order book for Q4, indicating potential recovery in sales.
- There was growth in the sub-supplier business by 2.3%, showcasing the effectiveness of their focus on sales and customer relationships.
- SP Group AS (OCSE:SPG) is expanding its capacity for medical device production in Poland, which is expected to contribute to future growth.
- The company has made several new agreements for future business within healthcare, clean tech, and defense, indicating potential for future revenue streams.
- Sales decreased by 3.3% in the first three quarters, with a significant reduction in sales of their own products by 16%.
- EBITDA and EBIT saw reductions of 6.7% and 8.9% respectively, reflecting the impact of decreased sales.
- The company experienced a slowdown in sales to healthcare and clean tech sectors.
- The Atlanta factory is currently operating at a loss due to startup costs and limited production, impacting overall profitability.
- There were order delays in Q3, partly due to external factors such as a terrorist incident, affecting the company's short-term performance.
/-
Hi and good afternoon. On behalf of Hans Christian Andersen Capital, I'd like to welcome you all to this presentation of the Q3 2025 report from SP Group that was published yesterday.
My name is Asmus Koibo, and I have the pleasure of welcoming CEO Lars Bing and CFO Tilli Kilhoff. They promised to take us through the quarterly numbers and recent highlights. So a warm welcome to you too.
And before I hand over, I'd also like to give a warm welcome to all of those of you who signed up for today's presentation. As usual, you can ask questions during the presentation in the chat room on your lower right corner. If you're not comfortable writing in English, you can write in Danish, and I'll help with the translation. So please don't hesitate to ask any questions you have for the management of this big group. But with that, I'll leave it to you, Lars and Tilda. Please go ahead.
- /
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
